Phreesia Inc
PHR
NYSE
Health Care
$12.51
USD
+1.09 (+9.54%)
At close: Aug 7, 2026, 4:00 PM EDT
Market Cap $780.68M
Volume 1.1M
About Phreesia Inc
Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The company is headquartered in Wilmington, Delaware and currently employs 1,789 full-time employees. The company went IPO on 2019-07-18. The firm's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The firm's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
HQ
Wilmington, DELAWARE, US
Founded
2019
Employees
1,789
Quantli Score
8.4
Outperform
Fin. Health
8.1
Profitability
7.6
Growth
9.0
Cash-Flow Q.
8.8
Key Metrics
6 metrics our research team weighs before forming a view on PHR.
Based on Quantli research · SEC filings · as of Q4 2026
METRIC
VALUE
CHANGE
TREND (3Y)
Revenue Growth (TTM)
14.5%
-3.3 pp
Gross Margin (TTM)
85.2%
+0.9 pp
Operating Margin (TTM)
-1.4%
+12.5 pp
Net Margin (TTM)
0.5%
+14.4 pp
ROE (TTM)
0.7%
+22.8 pp
Free Cash Flow (TTM)
$67.71M
+186.0%
Financial Snapshot
Revenue
$480.59M
+14.5%
YoY
Gross Margin
85%
TTM
+1.1%
YoY
Net Income
$2.31M
+103.9%
YoY
Operating Cash Flow
$78.81M
+143.4%
YoY
Key Statistics
Open
$12.60
Previous Close
$11.42
Day Range
$12.40 - $13.01
52 Week Range
$7.77 - $32.76
Volume
1.1M
Average Volume (10 Days)
800.0K
Dividend Yield
—
Valuation Measurement
Market Cap
$780.68M
P/E Ratio (TTM)
85.01
P/S Ratio (TTM)
1.62
Price / Book
2.32
Financial Highlights
Profit Margin
0.5%
Return on Assets
0.3%
Return on Equity
0.7%
Revenue (TTM)
$480.59M
Net Income (TTM)
$2.31M
Diluted EPS (TTM)
$0.03
Total Cash (MRQ)
$73.83M
Levered FCF (TTM)
$67.71M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Earnings Calendar
Next Earnings
Estimated Q2 Release
Sep 02
Est. EPS
Adjusted consensus estimate
$0.09
Analyst Consensus
Based on 6 analyst ratings
Avg Target: $12.17
(-2.7% upside)
High: $16.00 · Low: $9.00
Strong Buy
0%
Buy
33%
Hold
67%
Sell
0%
Strong Sell
0%